Hybrid Policy Kick-off Event:Innovative and Sustainable Modelsfor Drug Repurposing


BRUSSELS

JANUARY 15, 2025
12:00 PM

WATCH THE VIDEO RECAP
THE AGENDA

12:00 PM
Lunch reception

1:00 PM
Welcome

Arjon van Hengel – EC, Directorate-General for Research and Innovation (DG RTD.D PEOPLE, HEALTH&SOCIETY), Deputy Head of Unit D2 Health Innovations & Ecosystems (BE)
Monica Ensini – EC, Health & Digital Executive Agency (HaDEA), Unit A3 Health research, REPO4EU Project Adviser (BE)


1:05 PM
What are the validated research innovations in drug repurposing?

Harald Schmidt – REPO4EU Coordinator, Maastricht University (NL)


1:25 PM
Stimulating commercial investment in pharmaceutical development of drug repurposing research outputs

David Cavalla – Numedicus (UK)


1:45 PM
Panel 1 - The patients' and patient organisations' view

Marcos Mengual Hinojosa – Syngap Elternhilfe e.V. (DE)
Anneliene H. Jonker – Duchenne Parent Project (NL)
Ellen Koekoeckx – Foundation for Angelman Syndrome Therapeutics (US)
Joachim Maurice Mielert – Aktionsbündnis Patientensicherheit e.V. (DE)
Bernd Rosenbichler – Branewo (DE)


2:15 PM
Panel 2 - Regulatory innovations facilitating drug repurposing

Matthew L. Fedowitz – Buchanan (US)
Aaron S. Kesselheim – Harvard Medical School (US)
Yoana Nuevo Ordóñez – AEMPS, Agencia Española de Medicamentos y Productos Sanitarios (ES)
Marjon Pasmooij – CBG MEB Medicines Evaluation Board (NL)
Anja Schiel – NOMA Norwegian Medical Products Agency (NO)


2:45 PM
Coffee break

3:15 PM
Panel 3 - Successes and roadblocks in bringing drug repurposing to the patient

Saco de Visser – FAST Centre for Future Affordable and Sustainable Therapy Development (NL)
Hugo A. L. Filipe – RePo-SUDOE, Polytechnic of Guarda (PT)
Teun Grooters – Arega Medical (NL)
Hermann Mucke – H.M. Pharma Consultancy (AT)


3:45 PM
Panel 4 - Innovating reimbursement of repurposed drugs for fair returns on investments

François Houÿez – EURORDIS European Organisation for Rare Diseases (FR)
Sabine Grimm – Maastricht University Medical Center+ (NL)
Sibylle Reichert – Association Internationale de la Mutualité (BE)
Sibren van den Berg – Amsterdam UMC, RARE-NL (NL)


4:30 PM
Open discussion, recap and roadmap

Harald Schmidt – REPO4EU Coordinator, Maastricht University (NL)
Artur Olesch – about Digital Health (DE)


5:15 PM
Networking, drinks and healthy snacks

6:00 PM
Wrap-up and farewell
WHEN?

We will be gathering in Brussels on January 15, 2025, from 12 pm to 6 pm (local time). This first policy event will serve as an open platform to discuss the SIG goals and develop a roadmap to advocate for a EU-wide reimbursement strategy for repurposed drugs.

WHERE?

The event will take place at NH Brussels Carrefour de l’Europe, on Rue Marche aux Herbes 110, 1000 Brussels, Belgium. This is a face-to-face event but if it’s impossible for you to join in person, there will be an option to connect online.

By joining forces, we can ensure that repurposed drugs receive the attention and support they deserve, ultimately benefiting patients with innovative, effective, and affordable therapies. We look forward to your collaboration and contributions to this crucial initiative.
Your participation and insights will be invaluable in shaping the future of healthcare in Europe. Together, let’s make a rapid, cost-effective difference in patients’ lives across Europe.
REGISTER NOW